Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: art slott who wrote (683)	3/22/1998 2:51:00 PM
From: Shake-Man	Respond to of 1837

Seeing as how Cenestin is made synthetically and not using pregnant mares, I would suspect that actual production cost would be pennies on the dollar. Granted, they will have to share some of the profit with Parke Davis if they are the ones marketing it, but still DRMD should see millions in profit if the drug goes through and is accepted in the medical community. Even though it won't be a true generic equivalent to Premarin, if Cenestin is allowed to use "alternative to Premarin" or something similar in its advertising, people will jumping on it like maggots on a rotting corpse...perhaps I should have used a better euphemism there, but you get the picture.